Brief: Bristol Myers Squibb Announces Evolution of Research & Development Organization
BRIEF-Bristol Myers Squibb Announces Evolution of Research & Development Organization Nov 12 (Reuters) - Bristol-Myers Squibb Company BMY.N:
BRISTOL MYERS SQUIBB ANNOUNCES EVOLUTION OF RESEARCH & DEVELOPMENT ORGANIZATION
BRISTOL-MYERS SQUIBB COMPANY - CRISTIAN MASSACESI TO LEAD UNIFIED RESEARCH AND DEVELOPMENT ORGANIZATION EFFECTIVE JANUARY 1, 2027
BRISTOL-MYERS SQUIBB COMPANY - ROBERT PLENGE TO REMAIN IN ADVISORY CAPACITY THROUGH MARCH 2027 BEFORE DEPARTURE
BRISTOL-MYERS SQUIBB COMPANY - BMS TO COMBINE SCIENTIFIC AND CLINICAL EXPERTISE IN UNIFIED RESEARCH AND DEVELOPMENT ORGANIZATION JANUARY 1, 2027
Source text: ID:nBw9KWs96a
Further company coverage: BMY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bristol-Myers Squibb
See all newsAbbVie expands bispecific cancer med push with up to $2.5 billion deal with Germany's Disco
Bristol's schizophrenia drug helps Alzheimer's-related psychosis symptoms, preliminary data shows
Brief: Bristol Myers Squibb Presents First Clinical Data From Two Phase 3 Studies In The Adept Program Evaluating Karxt For Psychosis Associated With Alzheimer’S Disease
Brief: Sichuan Biokin Pharmaceutical's Unit Receives Milestone Payment From Bristol-Myers Squibb
Brief: Mubadala Investment Co PJSC Reports Stake In SpaceX, Pfizer, Adobe